Long-term follow-up after BCNU wafer implantation in patients with newly diagnosed glioblastoma. (April 2021)

• Record Type: Journal Article
• Authors: Shibahara, Ichiyo; Miyasaka, Kazuhiro; Sekiguchi, Akane; Ishiyama, Hiromichi; Inukai, Madoka; Yasui, Yoshie; Watanabe, Takashi; Sato, Sumito; Hide, Takuichiro; Kumabe, Toshihiro
• Is Part Of: Journal of clinical neuroscience. Volume 86(2021)
• Page Start: 202
• Page End: 210
• Publication Date: 2021-04
• Subjects: Glioblastoma -- Recurrence pattern -- Distant recurrence -- BCNU wafer -- Gliadel -- MR imaging -- Terminal stage; Brain -- Surgery -- Periodicals; Neurosciences -- Periodicals; Nervous system -- Surgery -- Periodicals; Brain -- surgery -- Periodicals; Neurosurgical Procedures -- Periodicals; Neurosciences -- Periodicals; Electronic journals; 616.8
• DOI: 10.1016/j.jocn.2021.01.037
• Languages: English
• ISSNs: 0967-5868

Abstract

Highlights: MRI follow-up until the terminal stage was conducted after BCNU wafer implantation. The recurrence pattern was determined by MRI or the radiation field. We histologically assessed an autopsy case after wafer implantation. Abstract: 1, 3-Bis(2-chloroethyl)-1-nitrosourea (BCNU, or Carmustine) wafers are intraoperatively implantable wafers used to achieve local tumor control. There is scarce data about the behavior of wafers in the long-term follow-up of implanted cases. We reviewed the data of 64 patients with newly diagnosed glioblastoma treated by surgery, BCNU wafers, radiation therapy, and temozolomide administration. This cohort included 55 patients who presented first recurrence, and 49 of them showed tumor progression to death. The MR imaging of each patient at the terminal stage and an autopsy case were used to elucidate the tumor progression pattern after the wafer implantation. We subdivided the first recurrence pattern into local, distant, and multifocal based on MR imaging or into infield, outfield, and marginal based on the radiation field. The first recurrence pattern was 33 patients (60%) with local, 13 (24%) with distant, and nine (16%) with multifocal recurrence, or 38 patients (69%) with infield, 13 (24%) with outfield, and four (7%) with marginal. The median and mean time intervals between MR imaging at the terminal stage and death were 2.0 and 2.3 months, respectively. Of note, 13 patients with first distant recurrence had no obvious radiological local tumor progression even at the terminal stage. Long-term follow-up after BCNU wafer implantation revealed that patients with first distant recurrence had long-lasting local tumor control until the terminal stage.